Economic Evaluation of Pharmaceuticals
- 1 October 1992
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 2 (4) , 270-278
- https://doi.org/10.2165/00019053-199202040-00003
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Discounting of Health Benefits in the Pharmacoeconomic Analysis of Drug TherapiesPharmacoEconomics, 1992
- Should there be a moratorium on the use of cholesterol lowering drugs?BMJ, 1992
- Quality of Life Instruments in the Evaluation of New DrugsPharmacoEconomics, 1992
- Economic Evaluation of PharmaceuticalsPharmacoEconomics, 1992
- Introduction: Lipids and coronary disease-resolved and unresolved problemsBritish Medical Bulletin, 1990
- Clinical benefits and cost-effectiveness of lowering serum cholesterol levels: The case of simvastatin and cholestyramine in The NetherlandsThe American Journal of Cardiology, 1990
- Medical costs of coronary artery disease in the United StatesThe American Journal of Cardiology, 1990
- Clinical economics. A guide to the economic analysis of clinical practicesJAMA, 1989
- QALYs: are they enough? A health economist's perspective.Journal of Medical Ethics, 1989
- Castigating QALYs.Journal of Medical Ethics, 1989